Researchers delve deeply into the genomics of 599 GBM brain cancer cases to better target the disease.
Researchers report genetic influences on head circumference remain stable during development and are correlated with genetic factors which contribute to intracranial volume.
Treating mouse models of astrocytomas with a new combination therapy resulted in tumor regression in 60% of the mice.
